LifeStance Health Group, Inc. (LFST) – Securities Investigation

Robbins Geller Rudman & Dowd LLP is investigating potential violations of U.S. federal securities laws by LifeStance Health Group, Inc. (NASDAQ: LFST) focused on whether LifeStance Health and certain of its officers and directors, as well as the underwriters of LifeStance Health’s June 2021 initial public offering, made false and misleading statements and/or failed to disclose material information to investors.

If you have information that could assist in this investigation or if you are a LifeStance Health investor who suffered a loss and would like to learn more, you can provide your information by clicking here.  You can also contact attorney Mary K. Blasy of Robbins Geller by calling 800/449-4900 or via e-mail at mblasy@rgrdlaw.com.

THE COMPANY: LifeStance Health provides virtual and in-person outpatient mental health care for children, adolescents, and adults experiencing a variety of mental health conditions.  On June 10, 2021, LifeStance Health went public by selling approximately 40 million shares of stock at $18 per share, raising nearly $550 million in net proceeds.  The offering documents touted LifeStance Health’s “demonstrated track record of growth” and repeatedly represented that LifeStance Health had built a “powerful organic growth engine” enabling LifeStance Health to drive growth.

THE REVELATION: Less than two months later, on August 11, 2021, LifeStance Health released its financial results for the second quarter of 2021, reporting a net loss of $70 million.  LifeStance Health also provided guidance for full year 2021 total revenue.  On this news, LifeStance Health’s stock price fell by more than 46%.

Then, on November 8, 2021, LifeStance Health released its financial results for the third quarter of 2021, reporting a net loss of $120.5 million compared to a net loss of only $3.3 million for the same period in the prior year.  On this news, LifeStance Health’s stock price fell by an additional 24%, further damaging investors.

ABOUT ROBBINS GELLER RUDMAN & DOWD LLP: Robbins Geller Rudman & Dowd LLP is one of the world’s leading complex class action firms representing plaintiffs in securities fraud cases.  The Firm is ranked #1 on the most recent ISS Securities Class Action Services Top 50 Report for recovering more than $1.75 billion for investors in 2022 – the third year in a row Robbins Geller tops the list.  And in those three years alone, Robbins Geller recovered nearly $5.3 billion for investors, more than double the amount recovered by any other plaintiffs’ firm.  With 200 lawyers in 10 offices, Robbins Geller is one of the largest plaintiffs’ firms in the world and the Firm’s attorneys have obtained many of the largest securities class action recoveries in history, including the largest securities class action recovery ever – $7.2 billion – in In re Enron Corp. Sec. Litig.